Press Releases

FAST-EU Trial 6 Month Results Published in Gynecological Surgery; 12 Month Results presented at 43rd Annual AAGL Meeting.

FDA Grants Approval To Commence SONATA Pivotal IDE Clinical Trial

Gynesonics names Richard P. Lanigan as Vice President, Global Commercialization.

Gynesonics announces first patient successfully treated with newly designed VizAbate System

Gynesonics Inc. announced today that it has received CE Mark approval for its next generation VizAblate® System enabling use throughout the European Union.

Gynesonics Inc., a women’s healthcare company focused on minimally invasive solutions for symptomatic uterine fibroids announces the appointment of Christopher M. Owens to president and Chief Executive Officer.

Gynesonics, Inc., a women’s healthcare company focused on minimally invasive solutions for symptomatic uterine fibroids, announced today a Series D financing led by HBM Partners based in Switzerland.